GBD 2016 Stroke Collaborators. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the global burden of Disease Study 2016. Lancet Neurol. 2019;18:439–58. https://doi.org/10.1016/S1474-4422(19)30034-1.

Article  Google Scholar 

GBD 2019 Diseases and Injuries Collaborators. Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the global burden of Disease Study 2019. Lancet. 2020;396:1204–22. https://doi.org/10.1016/S0140-6736(20)30925-9.

Article  Google Scholar 

Mohan KM, Wolfe CDA, Rudd AG, Heuschmann PU, Kolominsky-Rabas PL, Grieve AP. Risk and cumulative risk of stroke recurrence: a systematic review and meta-analysis. Stroke. 2011;42:1489–94. https://doi.org/10.1161/STROKEAHA.110.602615.

Article  PubMed  Google Scholar 

Crichton SL, Bray BD, McKevitt C, Rudd AG, Wolfe CDA. Patient outcomes up to 15 years after stroke: survival, disability, quality of life, cognition and mental health. J Neurol Neurosurg Psychiatry. 2016;87:1091–8. https://doi.org/10.1136/jnnp-2016-313361.

Article  PubMed  Google Scholar 

Edwards JD, Kapral MK, Fang J, Swartz RH. Long-term morbidity and mortality in patients without early complications after stroke or transient ischemic attack. CMAJ. 2017;189:E954–61. https://doi.org/10.1503/cmaj.161142.

Article  PubMed  PubMed Central  Google Scholar 

Wafa HA, Wolfe CDA, Emmett E, Roth GA, Johnson CO, Wang Y. Burden of stroke in Europe: thirty-year projections of incidence, prevalence, deaths, and disability-adjusted life years. Stroke. 2020;51:2418–27. https://doi.org/10.1161/STROKEAHA.120.029606.

Article  PubMed  PubMed Central  Google Scholar 

Cameron LJ, Wales K, Casey A, Pike S, Jolliffe L, Schneider EJ et al. Self-reported quality of life following stroke: a systematic review of instruments with a focus on their psychometric properties. Quality of life research: an international journal of quality of life aspects of treatment, care and rehabilitation 2021. https://doi.org/10.1007/s11136-021-02944-9.

Carod-Artal FJ, Egido JA. Quality of life after stroke: the importance of a good recovery. Cerebrovasc Dis. 2009;27(Suppl 1):204–14. https://doi.org/10.1159/000200461.

Article  PubMed  Google Scholar 

Greiner W, Witte J, Gensorowsky D. Nutzenbewertung Von Arzneimitteln in Deutschland: Schwerpunkt: Höchstpreise für Ein Mehr an Lebensqualität [AMNOG-Report 2019. Value Assessment of Parmaceuticals in Germany. Focus: Maximum prices for more health?]. Heidelberg: medhochzwei Verlag GmbH; Mai; 2019.

Google Scholar 

Golomb BA, Vickrey BG, Hays RD. A review of health-related quality-of-life measures in stroke. PharmacoEconomics. 2001;19:155–85. https://doi.org/10.2165/00019053-200119020-00004.

Article  CAS  PubMed  Google Scholar 

Pound P, Gompertz P, Ebrahim S. A patient-centred study of the consequences of stroke. Clin Rehabil. 1998;12:338–47. https://doi.org/10.1191/026921598677661555.

Article  CAS  PubMed  Google Scholar 

Salter KL, Moses MB, Foley NC, Teasell RW. Health-related quality of life after stroke: what are we measuring? Int J Rehabil Res. 2008;31:111–7. https://doi.org/10.1097/MRR.0b013e3282fc0f33.

Article  PubMed  Google Scholar 

Katzan IL, Thompson NR, Lapin B, Uchino K. Added value of patient-reported outcome measures in Stroke Clinical Practice. J Am Heart Assoc. 2017. https://doi.org/10.1161/JAHA.116.005356.

Article  PubMed  PubMed Central  Google Scholar 

EuroQol Group. EuroQol - a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199–208. https://doi.org/10.1016/0168-8510(90)90421-9.

Article  Google Scholar 

Devlin N, Parkin D, Janssen B. Methods for Analysing and reporting EQ-5D data. Cham (CH); 2020.

Devlin NJ, Brooks R. EQ-5D and the EuroQol Group: past, Present and Future. Appl Health Econ Health Policy. 2017;15:127–37. https://doi.org/10.1007/s40258-017-0310-5.

Article  PubMed  PubMed Central  Google Scholar 

Feng Y-S, Kohlmann T, Janssen MF, Buchholz I. Psychometric properties of the EQ-5D-5L: a systematic review of the literature. Qual Life Res. 2021;30:647–73. https://doi.org/10.1007/s11136-020-02688-y.

Article  PubMed  Google Scholar 

Golicki D, Niewada M, Karlińska A, Buczek J, Kobayashi A, Janssen MF, Pickard AS. Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients. Qual Life Res. 2015;24:1555–63. https://doi.org/10.1007/s11136-014-0873-7.

Article  PubMed  Google Scholar 

Hinz A, Kohlmann T, Stöbel-Richter Y, Zenger M, Brähler E. The quality of life questionnaire EQ-5D-5L: psychometric properties and normative values for the general German population. Qual Life Res. 2014;23:443–7. https://doi.org/10.1007/s11136-013-0498-2.

Article  PubMed  Google Scholar 

Golicki D, Niewada M, Buczek J, Karlińska A, Kobayashi A, Janssen MF, Pickard AS. Validity of EQ-5D-5L in stroke. Qual Life Res. 2015;24:845–50. https://doi.org/10.1007/s11136-014-0834-1.

Article  PubMed  Google Scholar 

Kangwanrattanakul K, Parmontree P. Psychometric properties comparison between EQ-5D-5L and EQ-5D-3L in the general Thai population. Qual Life Res. 2020;29:3407–17. https://doi.org/10.1007/s11136-020-02595-2.

Article  PubMed  Google Scholar 

Kangwanrattanakul K. Normative profile of the EQ-5D-5L dimensions, EQ-5D-5L index and EQ-VAS scores for the general Thai population. Qual Life Res. 2023;32:2489–502. https://doi.org/10.1007/s11136-023-03420-2.

Article  PubMed  Google Scholar 

Hunger M, Sabariego C, Stollenwerk B, Cieza A, Leidl R. Validity, reliability and responsiveness of the EQ-5D in German stroke patients undergoing rehabilitation. Qual Life Res. 2012;21:1205–16. https://doi.org/10.1007/s11136-011-0024-3.

Article  PubMed  Google Scholar 

Duncan PW, Wallace D, Lai SM, Johnson D, Embretson S, Laster LJ. The stroke impact scale version 2.0. Evaluation of reliability, validity, and sensitivity to change. Stroke. 1999;30:2131–40. https://doi.org/10.1161/01.str.30.10.2131.

Article  CAS  PubMed  Google Scholar 

Petersen C, Morfeld M, Bullinger M. Fragebogen über die Folgen eines Schlaganfalls. Testung Und Validierung Der Deutschen Version Der Stroke Impact scale [Questionnaire about the consequences of Stroke: testing and validation of the German version of the stroke impact scale (SIS)]. [Testing and validation of the German version of the stroke impact Scale]. Fortschr Neurol Psychiatr. 2001;69:284–90. https://doi.org/10.1055/s-2001-14465.

Article  CAS  PubMed  Google Scholar 

Owolabi MO. Which is more valid for stroke patients: generic or stroke-specific quality of life measures? Neuroepidemiology. 2010;34:8–12. https://doi.org/10.1159/000255460.

Reeves M, Lisabeth L, Williams L, Katzan I, Kapral M, Deutsch A, Prvu-Bettger J. Patient-reported outcome measures (PROMs) for Acute Stroke: Rationale, methods and future directions. Stroke. 2018;49:1549–56. https://doi.org/10.1161/STROKEAHA.117.018912.

Article  PubMed  Google Scholar 

Patrick DL, Deyo RA. Generic and disease-specific measures in assessing health status and quality of life. Med Care. 1989;27:S217–32. https://doi.org/10.1097/00005650-198903001-00018.

Article  CAS  PubMed  Google Scholar 

Duevel J, Elkenkamp S, Gensorowsky D, Brinkmeier M, Galle G, Miethe J. & Greiner W. A Case Management Intervention in Stroke Care: Evaluation of a quasi-experimental study. ZEFQ (Zeitschrift fuer Evidenz, Fortbildung und Qualitaet im Gesundheitswesen). 2024. https://doi.org/10.1016/j.zefq.2024.03.008

Violato M, Pollard J, Lloyd A, Roope LSJ, Duch R, Becerra MF, Clarke PM. The COVID-19 pandemic and health-related quality of life across 13 high- and low-middle-income countries: a cross-sectional analysis. PLoS Med. 2023;20:e1004146. https://doi.org/10.1371/journal.pmed.1004146.

Article  PubMed  PubMed Central  Google Scholar 

Ozkan H, Ambler G, Banerjee G, Chan E, Browning S, Mitchell J, et al. The impact of the UK COVID-19 pandemic on patient-reported health outcomes after stroke: a retrospective sequential comparison. J Neurol. 2022;269:1741–50. https://doi.org/10.1007/s00415-021-10819-9.

Article  CAS  PubMed  Google Scholar 

Farrell B, Godwin J, Richards S, Warlow C. The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry. 1991;54:1044–54. https://doi.org/10.1136/jnnp.54.12.1044.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rankin J. Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J. 1957;2:200–15. https://doi.org/10.1177/003693305700200504.

Article  CAS  PubMed  Google Scholar 

Banks JL, Marotta CA. Outcomes validity and reliability of the modified Rankin scale: implications for stroke clinical trials: a literature review and synthesis. Stroke. 2007;38:1091–6. https://doi.org/10.1161/01.STR.0000258355.23810.c6.